Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Andreas Bråve"'
Autor:
Ramona Groenheit, Philip Bacchus, Ilias Galanis, Klara Sondén, Ioana Bujila, Tatiana Efimova, Fredrik Garli, Oskar Karlsson Lindsjö, Mikael Mansjö, Elin Movert, Aleksandra Pettke, Marie Rapp, Maike Sperk, Sandra Söderholm, Karin Valentin Asin, Sarah Zanetti, Maria Lind Karlberg, Andreas Bråve, Kim Blom, Jonas Klingström
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 6, Pp 1240-1243 (2023)
We performed 2 surveys during 2022 to estimate point prevalences of SARS-CoV-2 infection compared with overall seroprevalence in Sweden. Point prevalence was 1.4% in March and 1.5% in September. Estimated seroprevalence was >80%, including among unva
Externí odkaz:
https://doaj.org/article/2505f1c815bf4b20bd2dd6ddf7aa1ee9
Autor:
Ramona Groenheit, Jessica Beser, Sharon Kühlmann Berenzon, Ilias Galanis, Edward van Straten, Jan Duracz, Marie Rapp, Disa Hansson, Mikael Mansjö, Sandra Söderholm, Shaman Muradrasoli, Anna Risberg, Richard Ölund, Andreas Wiklund, Kristoffer Metzkes, Matilda Lundberg, Philip Bacchus, Karin Tegmark Wisell, Andreas Bråve
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background In order to estimate the prevalence and understand the spread of SARS-CoV-2 in Sweden, the Public Health Agency of Sweden, with support from the Swedish Armed Forces, conducted a series of point prevalence surveys between March an
Externí odkaz:
https://doaj.org/article/0604a2bac4334bc3b16bc9e53716a4e0
Autor:
Kim Blom, Sebastian Havervall, Ulrika Marking, Nina Greilert Norin, Philip Bacchus, Ramona Groenheit, Andreas Bråve, Charlotte Thålin, Jonas Klingström
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 10, Pp 2119-2121 (2022)
Given the recent surge in SARS-CoV-2 Omicron infections, we performed a quantitative PCR screening survey during June 28–29, 2022, in Stockholm, Sweden, to investigate SARS-CoV-2 point prevalence in a group with high exposure risk. Results showed S
Externí odkaz:
https://doaj.org/article/23bc10cc489241e6b59238a0310edb1d
Autor:
Jessica Beser, Ilias Galanis, Theresa Enkirch, Sharon Kühlmann Berenzon, Edward van Straten, Jan Duracz, Marie Rapp, Katherina Zakikhany, Mikael Mansjö, Julia Wigren Byström, Mattias N. E. Forsell, Ramona Groenheit, Karin Tegmark Wisell, Andreas Bråve
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-4 (2022)
Abstract A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April–May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.6% of the pop
Externí odkaz:
https://doaj.org/article/baeec1c8d9ab4e29936f532c109b6f16
Autor:
Ramona Groenheit, Ilias Galanis, Klara Sondén, Maike Sperk, Elin Movert, Philip Bacchus, Tatiana Efimova, Lina Petersson, Marie Rapp, Viktoria Sahlén, Sandra Söderholm, Karin Valentin Asin, Sarah Zanetti, Maria Lind Karlberg, Andreas Bråve, Jonas Klingström, Kim Blom
Publikováno v:
The Lancet Regional Health. Europe, Vol 24, Iss , Pp 100564- (2023)
Externí odkaz:
https://doaj.org/article/f20384cfefe1437bbb4718e10591b70f
Autor:
Hedvig Glans, Sara Gredmark-Russ, Mikaela Olausson, Sara Falck-Jones, Renata Varnaite, Wanda Christ, Kimia T. Maleki, Maria Lind Karlberg, Sandra Broddesson, Ryan Falck-Jones, Max Bell, Niclas Johansson, Anna Färnert, Anna Smed-Sörensen, Jonas Klingström, Andreas Bråve
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic. The understanding of the transmission and the duration of viral shedding in SARS-CoV-2 infection is
Externí odkaz:
https://doaj.org/article/e00d500b4df24c6084920650bc15165e
Autor:
Kristian Alfsnes, Nina Lagerqvist, Sirkka Vene, Jon Bohlin, Jenny Verner-Carlsson, David Ekqvist, Andreas Bråve, Edward C. Holmes, Weifeng Shi, John H.-O. Pettersson
Publikováno v:
One Health, Vol 12, Iss , Pp 100217- (2021)
Pathogens associated with haemorrhagic fever commonly have zoonotic origins. The first documented imported case of likely viral severe haemorrhagic fever in Sweden occurred in 1990. Despite extensive study, no aetiological agent was identified. Follo
Externí odkaz:
https://doaj.org/article/d3602f05c6a544baacf0a1533cf8c70b
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 6, Pp 972-977 (2018)
Nosocomial transmission of Lassa virus (LASV) is reported to be low when care for the index patient includes proper barrier nursing methods. We investigated whether asymptomatic LASV infection occurred in healthcare workers who used standard barrier
Externí odkaz:
https://doaj.org/article/1fdb24a6911943bf9a2feed304040e25
Publikováno v:
Vaccines, Vol 7, Iss 3, p 64 (2019)
Background: Vaccination is commonly used to prevent and control influenza infection in humans. However, improvements in the ease of delivery and strength of immunogenicity could markedly improve herd immunity. The aim of this pre-clinical study is to
Externí odkaz:
https://doaj.org/article/4f24176e424d418c8fcdefd49adc70bb
Autor:
Steven E. Applequist, Shizuo Akira, Jorma Hinkula, Daniel X. Johansson, Ulf Schröder, Satoshi Uematsu, Björn Rissiek, Claudia Devito, Andreas Bråve, Tina Falkeborn, Sanna Nyström
Publikováno v:
Vaccines, Vol 1, Iss 4, Pp 415-443 (2013)
Eliciting effective immune responses using non-living/replicating DNA vaccines is a significant challenge. We have previously shown that ballistic dermal plasmid DNA-encoded flagellin (FliC) promotes humoral as well as cellular immunity to co-deliver
Externí odkaz:
https://doaj.org/article/86a6a229b046459b8fdb9589c2223be1